Literature DB >> 11146591

Neurological syndromes following organophosphate poisoning.

S Singh1, N Sharma.   

Abstract

Organophosphorous compounds, the anticholinesterases, produce significant morbidity and mortality in India. Although exact estimates are not available, hospital based statistics suggest that nearly half of the admissions to emergency with acute poisoning are due to organophosphates. Following accidental or suicidal exposure, these anticholinesterases lead to three well defined neurological syndromes i.e. initial life threatening acute cholinergic crisis which often requires management in intensive care unit, intermediate syndrome in which cranial nerve palsies, proximal muscle weakness and respiratory muscle weakness are common and patients often require respiratory support and delayed organophosphate induced polyneuropathy. In addition to these three classical neurological syndromes following acute exposure and in some following low dose chronic exposure, several neurobehavioural changes have been observed and these have been termed together as 'chronic organophosphate induced neuropsychiatric disorders' (COPIND). Organo-phosphate compounds produce significant pesticide related illness in developing countries. There is, thus, a need to determine exact extent of the problem and to develop appropriate strategies to manage these cases with available resources in these countries.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11146591

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  27 in total

1.  Sacral neuromodulation for the treatment of faecal incontinence in a patient with organophosphate poisoning.

Authors:  M Tayyab; R Arsalani-Zadeh; S Ullah; S Mehmood; P Waudby; G S Duthie
Journal:  Tech Coloproctol       Date:  2010-08-04       Impact factor: 3.781

Review 2.  Scenario of organophosphate pollution and toxicity in India: A review.

Authors:  Shardendu Kumar; Garima Kaushik; Juan Francisco Villarreal-Chiu
Journal:  Environ Sci Pollut Res Int       Date:  2016-02-26       Impact factor: 4.223

3.  Factors associated with outcomes in organophosphate and carbamate poisoning: a retrospective study.

Authors:  B Shrikar Reddy; Teny Grace Skaria; Sravani Polepalli; Sudha Vidyasagar; Mahadev Rao; Vijayanarayana Kunhikatta; Sreedharan Nair; Girish Thunga
Journal:  Toxicol Res       Date:  2020-02-07

Review 4.  Functional consequences of repeated organophosphate exposure: potential non-cholinergic mechanisms.

Authors:  A V Terry
Journal:  Pharmacol Ther       Date:  2012-03-20       Impact factor: 12.310

5.  Chronic impairments in spatial learning and memory in rats previously exposed to chlorpyrfos or diisopropylfluorophosphate.

Authors:  A V Terry; W D Beck; S Warner; L Vandenhuerk; P M Callahan
Journal:  Neurotoxicol Teratol       Date:  2011-10-17       Impact factor: 3.763

Review 6.  Neurotoxicity in acute and repeated organophosphate exposure.

Authors:  Sean X Naughton; Alvin V Terry
Journal:  Toxicology       Date:  2018-08-23       Impact factor: 4.221

7.  Soman induces ictogenesis in the amygdala and interictal activity in the hippocampus that are blocked by a GluR5 kainate receptor antagonist in vitro.

Authors:  J P Apland; V Aroniadou-Anderjaska; M F M Braga
Journal:  Neuroscience       Date:  2008-12-14       Impact factor: 3.590

8.  Sulfonylurea Class of Antidiabetic Drugs Inhibit Acetylcholinesterase Activity: Unexplored Auxiliary Pharmacological Benefit toward Alzheimer's Disease.

Authors:  Prayasee Baruah; Abhinandan Das; Debojit Paul; Suman Chakrabarty; Kripamoy Aguan; Sivaprasad Mitra
Journal:  ACS Pharmacol Transl Sci       Date:  2021-01-06

Review 9.  The physician's unique role in preventing violence: a neglected opportunity?

Authors:  John C Umhau; Karysse Trandem; Mohsin Shah; David T George
Journal:  BMC Med       Date:  2012-11-23       Impact factor: 8.775

10.  Effects of acute organophosphorus poisoning on function of peripheral nerves: a cohort study.

Authors:  Sudheera S Jayasinghe; Kithsiri D Pathirana; Nick A Buckley
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.